1. Introduction {#sec1}
===============

Paraquat (1,1-dimethyl-4,4-bipyridinium ion, PQ) is a highly effective herbicide, widely used on various crops for the last 60 years in over 130 countries. Although its standard use does not represent a serious poisoning risk to man due to its inactivation by the natural components of the soil, the ingestion of PQ often leads to severe clinical situations \[[@B1]\]. There were about 4000 deaths from paraquat poisoning reported in China between 1991 and 2008 \[[@B3]\], and the occurrence is on the rise. With no known antidote available, treatment of paraquat mostly relies on its removal from patients\' blood by hemoperfusion therapy and forced diuresis \[[@B4]\]. If the PQ concentrations in plasma and urine remain greater than 3 mg/L and 1 mg/L within a 24-hour period, respectively, the probability of patients\' survival is very low \[[@B5]--[@B7]\]. Therefore, rapid and accurate detection of PQ level within plasma and urine samples will help physicians to decide on treatment strategies and improves patients\' survival.

During the last few decades, a number of analytical methods have been reported for the identification and quantitation of paraquat in biological samples, which includes spectrophotometry \[[@B8], [@B9]\], gas chromatography (GC) \[[@B10]\], gas chromatography-mass spectrometry (GC-MS) \[[@B11], [@B12]\], high performance liquid chromatography (HPLC) \[[@B13], [@B14]\], high performance liquid chromatography coupled with mass spectrometry (HPLC-MS) \[[@B15]\], resonance light scattering technique (RLST) \[[@B16]\], voltammetry \[[@B17]\], and derivative spectroscopy \[[@B18]\]. Most of these methods often require expensive devices and professional operators, are associated with high cost, and thus are limited in clinical use. The UV spectrometry method, albeit generally accurate, relatively cheap, and simple to operate, is not well suited for PQ detection mainly due to matrix effects and the low concentration of PQ in biological samples. These drawbacks severely limit the availability of a diagnostic technology for detecting PQ poisoning, especially in remote and poor areas where the occurrence is particularly high. Therefore, developing an effective and inexpensive method for detecting PQ from different biological samples is of urgent importance for lowering fatality from PQ poisoning in clinic.

Recently, magnetic solid-phase extraction (MSPE) is increasingly used for sample preparation, as an adsorbent for the removal and/or preconcentration of many kinds of inorganic or organic pollutants \[[@B19], [@B20]\]. In MSPE procedures, magnetic adsorbents can be easily magnetized and gathered together in the presence of an external magnetic field and redispersed immediately once the magnetic field is removed, which greatly simplifies the SPE procedure and enhances the extraction efficiency. Most MSPE sorbents contain Fe~3~O~4~ nanoparticles (NPs) with modifications on surface chemical functional groups to improve specific binding to the target analytes and thus enable concentrations. Numerous organic and inorganic polymers have been used to modify Fe~3~O~4~ NPs \[[@B21], [@B22]\].

In the present study, we proposed, for the first time, to combine Fe~3~O~4~\@SiO~2~ NPs solid-phase extraction with UV-Vis for the absorption and determination of PQ in the plasma and urine samples free from any proteins and eluted PQ by sodium hydroxide-ascorbic acid. The free radical, the reduction product of PQ following the elution, is used for quantitative detection of PQ by UV-Vis spectrophotometry. Compared with the other reported methods in literature, the present method requires a simple and fast pretreatment of samples and presented a low limit of detection. The Fe~3~O~4~\@SiO~2~ NPs could be reused for five times. This method has been successfully applied to detect PQ in real plasma and urine sample, demonstrating high sensitivity that allows for fast assessment of patient outcome based on routine clinical parameters following the history of paraquat ingestion and thus facilitates the decision on treatment strategies.

2. Experimental {#sec2}
===============

2.1. Reagents {#sec2.1}
-------------

All reagents were of analytical grade or higher in purity and purchased from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China), unless otherwise specified. Milli-Q water (Millipore, Bedford, MA, USA) was used throughout the study. Britton-Robinson (B-R) buffer solutions were prepared by blending the mixed acid (0.04 mol/L H~3~PO~4~, HAc and H~3~BO~3~) with 0.2 mol/L NaOH in proportion. PQ was obtained from the Chinese National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China) without further treatment. A 1000 ng/mL of paraquat stock solution was prepared by dissolution of the dichloride salt in water. Working solutions were prepared by dilution of the stock solution with water. Sodium dithionite was unstable in the presence of moisture and kept in a desiccator.

2.2. Apparatus {#sec2.2}
--------------

All spectra measurements were carried out using a model UV-2501 spectrophotometer (Shimadzu Corporation, Japan) with matched quartz cells. All pH values were measured by a PHS-25B pH meter (Shanghai Precision & Scientific Instrument Co., Ltd., Shanghai, China). FT-IR spectra were measured with a Bruker Tensor 27 spectrometer (Bruker Company, Germany). Samples were pressed into KBr pellets and recorded at the frequencies from 4000 to 400 cm^−1^ with a resolution of 4 cm^−1^.

2.3. Preparation of Fe~3~O~4~\@SiO~2~ NPs {#sec2.3}
-----------------------------------------

Fe~3~O~4~ NPs were prepared by the conventional coprecipitation method \[[@B23]\]. First, FeCl~3~ (6.28 g) was dissolved in deionized water (150 mL) followed by addition of polyethylene glycol (30 mL, 20%, w/w) and of (NH~4~)~2~Fe(SO~4~)~2~ (7.84 g) water solution under stirring. Then ammonium hydroxide (20 mL, 26.5%, w/w) was added rapidly under vigorous stirring. The resultant solution was stirred (1000 r·min^−1^) at 80°C for 60 min. After cooling to room temperature, the obtained Fe~3~O~4~ precipitate was collected by an external magnetic field, washed with deionized water five times, and dried at 60°C for 12 h in vacuum.

Fe~3~O~4~\@SiO~2~ was prepared according to the literature method \[[@B24]\]. Fe~3~O~4~ (1.0 g) were dissolved in 150 mL of ethanol and 30 mL of deionized water by sonication for 15 min, and then 2 mL of ammonium hydroxide and 4 mL of tetraethyl orthosilicate (TEOS) were added. The mixture was allowed to react for 6 h at 60°C under continuous stirring. The resultant product was collected by an external magnetic field, rinsed with deionized water and ethanol for six times thoroughly, and dried in vacuum to obtain Fe~3~O~4~\@SiO~2~ NPs.

2.4. MSPE Procedure {#sec2.4}
-------------------

To process a plasma or urine sample, 20.0 mg of Fe~3~O~4~\@SiO~2~ NPs was added to a 40 mL polyethylene tube with a cap, and the spiked plasma or urine sample was pipetted into the tube. The tube was vortexed for 10 min for extraction. Then the Fe~3~O~4~\@SiO~2~ NPs were gathered and kept static for 1 min with an externally applied Nd-Fe-B permanent magnet. The Fe~3~O~4~\@SiO~2~ NPs adsorbent was washed twice under vertexing (30 s/wash) in 1 mL water. Once the suspension became limpid, the supernatant was pipetted out. The isolated Fe~3~O~4~\@SiO~2~ NPs were eluted with 0.2 mL of 6.0 mol/L NaOH and 0.8 mL of 50 g/L ascorbic acid to elute the preconcentrated target analytes. The eluted solution was collected and then transferred into a microcell for the detection of target analyte by UV-Vis. The whole time of the process was about 20 min. The general extraction procedure is illustrated in [Figure 1](#fig1){ref-type="fig"}.

2.5. Sample Preparation {#sec2.5}
-----------------------

This study was approved by the Ethics Committee of the Huaihai Institute of Technology (Lianyungang, China). Human plasma and urine samples were obtained from patients of PQ intoxication and healthy adults with no known record of occupational exposure to PQ (as blank) from the First People\'s Hospital of Lianyungang (as detailed below). Written consent was signed by all participants. Plasma and urine samples spiked with standard PQ stock solutions to indicate concentrations were used as positive controls. The venous blood was drawn from the forearm of each subject and immediately transferred to vessels containing heparin as an anticoagulant. Plasma was separated by centrifugation at 4000 rpm for 10 min and stored at 4°C.

Urine samples were collected in accordance with conventional sampling practices using 100 mL clear vials with polytetrafluoroethylene-lined screw caps. The samples were stored at −4°C in a refrigerator.

3. Results and Discussion {#sec3}
=========================

3.1. Characterization of the Fe~3~O~4~\@SiO~2~ NPs {#sec3.1}
--------------------------------------------------

The Fe~3~O~4~ and Fe~3~O~4~\@SiO~2~ MNPs were characterized using Fourier transform infrared (FT-IR) spectroscopy ([Figure 2(a)](#fig2){ref-type="fig"}) and magnetic characterization ([Figure 2(b)](#fig2){ref-type="fig"}), respectively. As shown in [Figure 2(a)](#fig2){ref-type="fig"}, the peak at 580 cm^−1^ in curve (A) was assigned to Fe-O-Fe stretching vibrations and the strong peaks at 1200--1000 cm^−1^ in curve (B) corresponded to Si-O-H and Si-O-Si stretching vibrations, indicating that SiO~2~ had been successfully loaded onto the surface of Fe~3~O~4~. The magnetic hysteresis loops of the two types of MNPs were shown in [Figure 2(b)](#fig2){ref-type="fig"}. It is apparent that both of Fe~3~O~4~ and Fe~3~O~4~\@SiO~2~ showed superparamagnetic properties due to the core magnetite particles. Magnetic characterization using a magnetometer at 25°C indicated that the maximal saturation magnetizations of the Fe~3~O~4~ and Fe~3~O~4~\@SiO~2~ were 96.3 and 84.7, respectively. Due to their superparamagnetism and large saturation magnetization, Fe~3~O~4~\@SiO~2~ could be rapidly separated from the solution using a magnet.

3.2. Optimizations of PQ Extraction {#sec3.2}
-----------------------------------

To optimize the extraction procedure of PQ, we focused on the following factors: pH, the amount of Fe~3~O~4~\@SiO~2~ MNPs, temperature, the extraction time, and the sample volume.

### 3.2.1. pH {#sec3.2.1}

pH is a crucial factor affecting the extraction efficiency of PQ (*E*~PQ~). In this work, the effect of pH was investigated over the range of 4.0 to 13.0. As shown in [Figure 3(a)](#fig3){ref-type="fig"}, *E*~PQ~% increased with the pH and reached plateau between the pH range of 6.8--12.0. Therefore, pH 7.0 was selected for the subsequent assays.

The spectra of PQ reduced by ascorbic acid before and after the extraction were shown as curve 1 and curve 2, respectively, in [Figure 3(b)](#fig3){ref-type="fig"}. No noticeable differences are found between the two spectral curves. This means that no direct chemical (bonding) interactions were involved between Fe~3~O~4~\@SiO~2~ MNPs and PQ. The speciation of PQ was not changed after the magnetic solid-phase extraction.

### 3.2.2. The Amount of Fe~3~O~4~\@SiO~2~ MNPs {#sec3.2.2}

To assess the effect of the amount of Fe~3~O~4~\@SiO~2~ MNPs on PQ extraction, we studied the Fe~3~O~4~\@SiO~2~ MNPs within the range of 5.8 to 32 mg. As shown in [Figure 3(b)](#fig3){ref-type="fig"}, *E*~PQ~% increased in a dose-dependent manner within the amount range of Fe~3~O~4~\@SiO~2~ MNPs between 5.0 mg and 15 mg and kept stable after 15 mg ([Figure 3(b)](#fig3){ref-type="fig"}). Therefore 20 mg of Fe~3~O~4~\@SiO~2~ MNPs was selected for further experiments.

### 3.2.3. The Extraction Time {#sec3.2.3}

To evaluate the effect of extraction time on *E*~PQ~%, different extraction times ranging from 1 to 17 min were tested ([Figure 3(c)](#fig3){ref-type="fig"}). *E*~PQ~% gradually increased up to 5 min and remained relatively constant thereafter. Furthermore, the absorbance of PQ in NaOH medium following the reduction by ascorbic acid remained unaltered in response to the extraction time of 5.0--17 min. Thus the extraction time of 10 min was selected for further study.

### 3.2.4. The Sample Volume {#sec3.2.4}

The effect of sample volume was examined between the sample volume of 3.0--70.0 mL that contained a fixed amount of PQ. The data ([Figure 3(d)](#fig3){ref-type="fig"}) show that *E*~PQ~% decreased when the sample volume was greater than 35.0 mL. Therefore, the maximum sample volume could be set as 35.0 mL.

### 3.2.5. Adsorption Capacity {#sec3.2.5}

The adsorption capacity (the maximal amount of extracted analyte from 1.0 g of extractant) is an important parameter to evaluate the efficiency. In this work, the adsorption capacity of Fe~3~O~4~\@SiO~2~ MNPs for PQ was studied by varying the amount of PQ in aqueous samples before the SPE procedure. As shown in [Figure 4](#fig4){ref-type="fig"}, the adsorption capacity reached a maximum value when the concentration of PQ (*C*~PQ~) was 1.57 *μ*g·mL^−1^. Given that the amount of Fe~3~O~4~\@SiO~2~ MNPs was set as 20 mg, the maximal adsorption capacity of Fe~3~O~4~\@SiO~2~ MNPs was calculated as approximately 2.4 mg/g for PQ.

3.3. Optimization of Desorption {#sec3.3}
-------------------------------

### 3.3.1. The Selection and the Volume of Eluents {#sec3.3.1}

Though PQ could be absorbed by Fe~3~O~4~\@SiO~2~ NPs, its reduction product, the blue free radical, could not be absorbed. Utilizing this feature, NaOH and ascorbic acid, which provided the alkaline environment and acted as reductant, respectively, were adopted as eluents in this study. The volume effect of NaOH and ascorbic acid solution on the elution efficiency of PQ was evaluated in detail. The volume of total eluents, including NaOH, ascorbic acid, and water, was fixed at 1.0 mL. The results showed that absorbance was kept stable when the volumes of 6.0 mol/L NaOH and 50 g/L ascorbic acid were higher than 0.16 mL and 0.5 mL, respectively (Figures [5(a)](#fig5){ref-type="fig"} and [5(b)](#fig5){ref-type="fig"}). So 0.2 mL 6 mol/L NaOH and 0.8 mL 50 g/L ascorbic acid were selected. The preconcentration factor (the quotient of volume before absorption and after elution) was 35.

### 3.3.2. Elution Time {#sec3.3.2}

The experimental results showed that the elution efficiency of NaOH and ascorbic acid increased up to 95.0% after 30 s stripping time ([Figure 6(a)](#fig6){ref-type="fig"}). Thus, 1 min was selected as the optimal elution time.

### 3.3.3. Reusability of the Fe~3~O~4~\@SiO~2~ {#sec3.3.3}

After desorption, the Fe~3~O~4~\@SiO~2~ was washed for 30 s twice by the mixture solution (1 mL 6.0 mol/L NaOH and 1 ml 50 g/L ascorbic acid) and water, respectively. Then it was dried with heating at 105°C. The extraction efficiency of the recycled Fe~3~O~4~\@SiO~2~ for PQ remained above 95.0% after at least five recycles ([Figure 6(b)](#fig6){ref-type="fig"}). Thus, the Fe~3~O~4~\@SiO~2~ could be used repeatedly for five times.

3.4. Tolerance of Contaminants {#sec3.4}
------------------------------

To assess the tolerance limit of this procedure, we set the detection sensitivity of PQ to 40 *μ*g/L. With a relative error of less than ±5%, the tolerance limits for various foreign ions were shown in [Table 1](#tab1){ref-type="table"} (tolerance ratio in mass). The results indicate that the majority of these contaminants presented no remarkable interference on the determination of PQ.

3.5. Analytical Performance {#sec3.5}
---------------------------

Under the optimal conditions, a linear calibration curve was established in the PQ concentration range of 15.0--400.0 *μ*g/L. The equation for the calibration graph is *A* (absorbance) = 0.0049 + 0.0016*C* (*μ*g/L), with a correlation coefficient of 0.9987. The limit of detection (LOD), defined as LOD = 3*σ*/*k* (where *σ* is the standard deviation of the blank sample and *k* is the slope of the calibration graph), was 12.2 *μ*g/L. The relative standard deviation was 0.65% (*n* = 5, *c* = 40.0 *μ*g/L). The preconcentration factor, defined as the quotient of the volumes before the absorption and after the elution, is 35-fold.

[Table 2](#tab2){ref-type="table"} offers a comparative analysis of the current method and the previously developed methods. It revealed that the cost of the combining MSPE with UV spectroscopy is relatively cheap for the common instrument and reagent. It is also rapid and easy to operate and has the same sensitivity, as compared to other reported methods.

To examine the performance of this proposed method, we obtained plasma and urine samples from either PQ patients or healthy controls from the First People\'s Hospital of Lianyungang City. In order to assess the accuracy of the proposed method, recovery studies were also performed on the corresponding samples by determining known amounts of PQ added to the samples at above-mentioned concentration levels ([Table 3](#tab3){ref-type="table"}). [Table 3](#tab3){ref-type="table"} shows that the recoveries of the PQ ranged from 92.9% to 105.2%.

3.6. Clinical Application {#sec3.6}
-------------------------

This proposed method was applied to the emergency case of paraquat poisoning. A 28-year-old woman was admitted to the local hospital department after intentionally ingesting some of 20% paraquat solution for 60 minutes. Plasma and urine samples were collected before and after the hemoperfusion therapy and tested for the levels of paraquat on admission. The interval time of hemoperfusion was set as 8 hours. The plasma concentrations of paraquat, detected by this proposed method and HPLC method \[[@B28]\], were reduced with the increased number of the hemoperfusion therapies ([Table 4](#tab4){ref-type="table"}). Applying the paired *t*-test using the comparative method and the proposed method, the calculated *t* values were smaller than the critical value (2.776, *α* = 0.05).

These results demonstrate the applicability of the combining MSPE with UV spectroscopy for the determination of paraquat in human plasma and urine samples.

4. Conclusion {#sec4}
=============

Fe~3~O~4~\@SiO~2~ MNPs were successfully prepared and applied as magnetic adsorbents to preconcentrate and separate PQ. Featuring the rapid collection of Fe~3~O~4~\@SiO~2~ MNPs from the sample using an external magnetic field, easy elution with more environmental solvent, excellent enrichment in low time, and good precision and high accuracy, this extraction procedure proved to be a useful and convenient method for quantitative evaluation of paraquat in biological samples. Compared with other reported methods, this technique is simple, inexpensive, and fast. Through this study, the optimal conditions for PQ detection are established and validated using the plasma and urine samples from human patients suffering PQ poisoning and from healthy adults through the recovery experiment. The results indicated that the developed MSPE-UV-Vis method is suitable for detecting PQ poisoning in clinic. Early detection and quantification of PQ will no doubt benefit patient treatment and survival. We are investigating the application potential of this novel method in clinical studies and evaluating its significance on improving patient outcomes.
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![Schematic of the MSPE procedure for detecting PQ using Fe~3~O~4~\@SiO~2~ NPs.](JAMC2017-8704639.001){#fig1}
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![Factors affecting the extraction efficiency. The extraction efficiency (*E*~PQ~%) was determined as a function of pH (a), the amount of Fe~3~O~4~\@SiO~2~ (b), the extraction time (c), and the sample volume (d).](JAMC2017-8704639.003){#fig3}
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###### 

Effect of contaminants for detecting 40 *μ*g/L PQ.

  Contaminants                             Tolerance limits
  ---------------------------------------- ------------------
  K^+^, Na^+^, Zn^2+^                      1000
  Chlorophyll, lutein                      600
  Cd^2+^, Mg^2+^, PO~4~^3−^                500
  2,4-D, 2,4,5-T, DDT, Kelthane, lindane   200
  Cu^2+^, Ni^2+^, Ca^2+^, Fe^2+^, Mn^2+^   100
  Al^3+^                                   40
  Fe^3+^, Pb^2+^                           20
  Aquacide                                 5

DDT: dichlorodiphenyltrichloroethane.

###### 

Comparison of the MSPE + UV method with other analytical techniques for extraction and determination of PQ.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------
  Sample                  Extraction and detection technique   Extract method and extractant   Linear range (*μ*g/L)   Limits of detection (*μ*g/L)   Ref.
  ----------------------- ------------------------------------ ------------------------------- ----------------------- ------------------------------ ------------
  Urine                   UV-Vis                               ---                             1000--1500              ---                            \[[@B9]\]

  Human blood             UV-Vis                               LLE dichloromethane             84.1--841               89.1                           \[[@B25]\]

  Human blood and urine   GC                                   ---                             1 × 10^3^--7 × 10^4^    ---                            \[[@B10]\]

  Plasma and urine        GC-MS                                SPE\                            100--50000              50                             \[[@B11]\]
                                                               C~18~ cartridge                                                                        

  Urine                   GC-MS                                HS-SPME\                        10--1000                0.1                            \[[@B12]\]
                                                               fiber                                                                                  

  Plasma                  HPLC-UV                              ---                             2 × 10^5^--5 × 10^8^    ---                            \[[@B13]\]

  Whole blood             HPLC-UV                              ---                             300--30000              26                             \[[@B27]\]

  Human plasma            HPLC- UV                             SPE\                            20--1 × 10^4^           10                             \[[@B28]\]
                                                               Xtimate C18 column                                                                     

  Urine                   HPLC-MS                              DSPE\                           3.75--375.0             0.94                           \[[@B15]\]
                                                               Carbon nanotube                                                                        

  Plasma and urine        UV-Vis                               SPE\                            15--400                 4.7                            This work
                                                               SiO~2~\@Fe~3~O~4~                                                                      
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------

HS-SPME: headspace solid phase microextraction; DSPE: dispersive solid phase extraction.

###### 

Determination of PQ in different plasma and urine samples (*n* = 3).

  --------------------------------------------------------------------------------------------------
  Sample                       PQ content in sample   Added (*μ*g/L)   Found (*μ*g/L)   Recovery/%
  ---------------------------- ---------------------- ---------------- ---------------- ------------
  Plasma from healthy adults   ND\                    0                ND               ---
                               (3.0 mL plasma)                                          

  40.0                         38.5 ± 1.7             96.2                              

  80.0                         78.1 ± 0.8             97.6                              

  Plasma from PQ patients      31.50 ng/mL\           0                9.5 ± 0.2        ---
                               (3.0 mL plasma)                                          

  5                            14.6 ± 0.9             102.4                             

  10                           18.8 ± 1.4             93.6                              

  Urine from healthy adults    ND\                    0                ND               ---
                               (100.0 mL)                                               

  100.0                        95.8 ± 1.2             95.8                              

  200.0                        185.8 ± 4.1            92.9                              

  Urine from PQ patients       78.92 ng/mL\           0                39.5 ± 1.4       ---
                               (50.0 mL)                                                

  20.0                         60.2 ± 3.0             103.5                             

  40.0                         77.4 ± 1.8             94.8                              
  --------------------------------------------------------------------------------------------------

ND, nondetectable.

###### 

Determination of PQ in plasma and urine sample with different hemoperfusion numbers by the proposed method and HPLC (*n* = 3).

  Number of HP   Plasma/(×10^3^ *μ*g/L)   Urine/(×10^3^ *μ*g/L)                 
  -------------- ------------------------ ----------------------- ------------- -------------
  0              6.84 ± 0.04              6.89 ± 0.04             8.54 ± 0.08   8.63 ± 0.07
  1              3.32 ± 0.09              3.44 ± 0.10             1.26 ± 0.12   1.42 ± 0.13
  2              1.05 ± 0.12              1.19 ± 0.11             0.24 ± 0.05   0.20 ± 0.05
  3              0.34 ± 0.09              0.45 ± 0.09             ND            ND
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